Avera Pharmaceuticals

Ownership

Private

Therapeutic Areas

Neurology

Stage

Phase 2

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Small molecules

Avera Pharmaceuticals General Information

A specialty pharmaceutical company that acquires, develops, and commercializes pharmaceutical compounds, with a focus on CNS therapeutics.

Contact Information

Website

https://www.zoominfo.com/c/avera-pharmaceuticals-inc/3555835

Primary Industry

Biotech

Corporate Office

San Diego, California
United States

Drug Pipeline

AV-608

Phase 2

Indications: Lorem ipsum dolor sit

Modality: Lorem ipsum

Drug Asset 2

Phase X

Indications: Lorem ipsum dolor sit

Modality: Lorem ipsum

Drug Asset 3

Phase X

Indications: Lorem ipsum dolor sit

Modality: Lorem ipsum

For full access to Avera Pharmaceuticals's pipeline data

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Avera Pharmaceuticals Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view Avera Pharmaceuticals's complete valuation and funding history, request access »

Avera Pharmaceuticals Financial Metrics